Clinical Trial Update: Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the efficacy and safety of M518101 in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• M518101

Snippet

Sponsor: Maruho North America Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED